---
title: "Some directors and senior executives of Chongqing Department Store plan to reduce their holdings by a total of no more than 130,700 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241004907.md"
description: "According to the Zhitong Finance APP, Chongqing Department Store announced that due to personal funding needs, some directors and senior executives of the company plan to reduce their holdings of the company's shares by a total of no more than 130,700 shares through centralized bidding within three months after the disclosure date of this announcement, starting from 15 trading days thereafter"
datetime: "2025-05-20T10:10:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241004907.md)
  - [en](https://longbridge.com/en/news/241004907.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241004907.md)
---

# Some directors and senior executives of Chongqing Department Store plan to reduce their holdings by a total of no more than 130,700 shares

According to the announcement from Zhitong Finance APP, Chongqing Department Store (600729.SH) announced that due to personal funding needs, some directors and senior executives of the company plan to reduce their holdings of the company's shares by a total of no more than 130,700 shares through centralized bidding within three months after 15 trading days from the date of this announcement

### Related Stocks

- [600729.CN](https://longbridge.com/en/quote/600729.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [12:11 ETOysterLink Reveals the Most In-Demand Hospitality Jobs in April 2026](https://longbridge.com/en/news/286943400.md)
- [16:51 ETBeverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons](https://longbridge.com/en/news/286966075.md)
- [Palfinger wins Dragados order for seven davit cranes for North Sea HVDC platforms](https://longbridge.com/en/news/287017946.md)
- [Poxel wins Japan patent for imeglimine use in type 2 diabetes patients with renal impairment](https://longbridge.com/en/news/287013341.md)